pleural effusion - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased capillary permeability leads to the leakage of fluid into the pleural space, often due to inflammation or infection (e.g., pneumonia), causing an imbalance between fluid production and reabsorption.

• Secondary mechanism: Decreased lymphatic drainage caused by obstruction or damage to lymphatic vessels can result in fluid accumulation, as the lymphatic system fails to clear excess fluid effectively.

• Key complication: Accumulated fluid in the pleural space can compress lung tissue, leading to impaired gas exchange and respiratory distress, which can exacerbate underlying respiratory conditions if not managed promptly.

Patient Profile

Demographics:

62-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, chronic obstructive pulmonary disease (COPD), history of smoking (30 pack-years), previous episode of pneumonia

• Current medications: Lisinopril, Albuterol inhaler, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and chest discomfort

• Key symptoms: Progressive dyspnea, non-productive cough, mild fever, decreased breath sounds on right side, fatigue

• Vital signs: Blood pressure 145/90 mmHg, heart rate 108 bpm, respiratory rate 28 breaths per minute, temperature 100.1°F, oxygen saturation 89% on room air

Section 1

Change in Patient Status

As the healthcare team continues to monitor the patient, there is a noticeable change in her clinical status. Her oxygen saturation has further decreased to 84% despite being placed on supplemental oxygen at 2 liters per minute via nasal cannula. The patient is now visibly distressed, exhibiting increased work of breathing characterized by the use of accessory muscles and intercostal retractions. Her respiratory rate has climbed to 32 breaths per minute, and her heart rate has increased to 118 bpm. Her blood pressure remains elevated at 150/95 mmHg, and her temperature is slightly higher at 100.4°F. The patient reports feeling more fatigued and is experiencing increased chest discomfort.

A focused reassessment reveals diminished breath sounds on the right side, with dullness to percussion noted over the lower half of the right thorax, suggesting a significant pleural effusion. Crackles are also heard at the right lung base, indicating possible consolidation. As the team evaluates these findings, they recognize the need for urgent intervention to address the acute respiratory compromise and prevent further deterioration. The decision is made to initiate a higher level of oxygen therapy and to prepare for a potential thoracentesis to relieve the pleural effusion. This change in the patient's status prompts a reconsideration of the underlying causes, such as the possibility of a worsening infectious process or heart failure contributing to the pleural fluid accumulation, guiding further diagnostic and therapeutic interventions.

Section 2

Following the decision to escalate care, the healthcare team increases the patient's oxygen delivery by transitioning from a nasal cannula to a non-rebreather mask at 15 liters per minute. Despite this intervention, the patient's oxygen saturation only marginally improves to 88%. Recognizing the need for more aggressive measures, the team swiftly prepares for a thoracentesis. Meanwhile, a chest X-ray is ordered urgently, confirming a large pleural effusion on the right side with possible underlying consolidation, which could suggest a pneumonia exacerbating the patient's condition.

Laboratory results return, further complicating the clinical picture. The patient's white blood cell count is elevated at 18,000/µL, indicating an inflammatory or infectious process. Her C-reactive protein level is also significantly increased, supporting the suspicion of an infectious etiology. Blood cultures are obtained, and broad-spectrum antibiotics are initiated empirically to cover potential pathogens. The team begins to consider whether her pleural effusion is primarily due to an infectious process, such as parapneumonic effusion or empyema, or if there is a cardiac component, given her elevated blood pressure and tachycardia.

Shortly after the thoracentesis, the patient's respiratory status shows slight improvement, with her respiratory rate decreasing to 28 breaths per minute and a modest increase in oxygen saturation to 91%. Fluid analysis from the thoracentesis reveals exudative characteristics, with a high protein content and the presence of neutrophils, aligning with an infectious cause. Despite initial relief, the patient's fever persists, and her heart rate remains elevated, prompting the healthcare team to consider additional imaging, such as a CT scan of the chest, and to reassess her antibiotic regimen based on culture results to ensure appropriate coverage. This evolving scenario necessitates vigilant monitoring and dynamic clinical reasoning to prevent further complications and guide the patient's recovery.

Section 3

As the healthcare team closely monitors the patient, they notice a change in her status that requires immediate attention. Approximately six hours post-thoracentesis, the patient begins to exhibit increased work of breathing, with a respiratory rate spiking to 34 breaths per minute. Her oxygen saturation, despite being on the non-rebreather mask, has now decreased to 85%, suggesting a potential complication or progression of her underlying condition. Auscultation of the chest reveals decreased breath sounds on the right side, with dullness to percussion, raising concerns about potential re-accumulation of pleural fluid or worsening consolidation.

To better delineate these findings, a stat chest CT scan is performed, revealing a significant loculated pleural effusion with evidence of septations, suggesting the development of an empyema. Additionally, areas of dense consolidation in the right lower lobe are observed, confirming the presence of a severe pneumonia. The CT findings, coupled with the patient's persistent fever and elevated heart rate of 110 beats per minute, indicate that the current antibiotic regimen may not be sufficiently addressing the infection.

In response to these developments, the healthcare team decides to consult with thoracic surgery to evaluate the need for a possible surgical intervention, such as video-assisted thoracoscopic surgery (VATS), to effectively drain the empyema. Concurrently, the patient's antibiotic coverage is adjusted based on preliminary culture results, which have identified a resistant strain of bacteria. The team opts to switch to a more targeted antibiotic to better combat the specific pathogen. This dynamic clinical situation requires the team to continuously reassess and adapt their approach to stabilize the patient and prevent further deterioration.

Section 4

As the thoracic surgery team prepares for potential intervention, the healthcare team focuses on the patient's response to the newly adjusted antibiotic regimen. Within 24 hours, the patient's condition begins to show subtle signs of improvement. Her respiratory rate decreases to 28 breaths per minute, and her oxygen saturation rises to 90% with continued support from the non-rebreather mask. However, her fever persists at 101.5°F, and her heart rate remains elevated at 108 beats per minute, indicating that while the infection is being addressed, there is still a significant inflammatory response.

Repeat laboratory evaluations reveal a slight improvement in her white blood cell count, now at 15,000/mm³, down from a previous high of 18,000/mm³. Inflammatory markers such as C-reactive protein (CRP) and procalcitonin remain elevated but are trending downward, suggesting that the targeted antibiotic therapy is beginning to take effect. Blood cultures have confirmed the presence of a resistant strain of Streptococcus pneumoniae, supporting the decision to shift the antibiotic regimen. Despite these positive developments, the patient is experiencing increased fatigue and reports mild, localized pleuritic chest pain, which raises concerns about the ongoing empyema and potential pleural irritation.

These evolving clinical findings prompt the team to maintain close monitoring and frequent reassessments, ensuring timely identification of any new complications. Discussions with the thoracic surgery team continue, with plans for a VATS procedure set to proceed if there is no significant improvement in the empyema within the next 48 hours. The healthcare team remains vigilant, ready to adjust their plan of care based on the patient's response, with the overarching goal of stabilizing her condition and preventing further respiratory compromise.

Section 5

As the healthcare team continues to monitor the patient's progress, new diagnostic imaging results provide additional insights into her condition. A repeat chest X-ray reveals a slight reduction in the size of the pleural effusion, suggesting that the antibiotic therapy is having some impact. However, the presence of loculated fluid collections is noted, which complicates the picture. These pockets of infection may not respond as readily to antibiotic treatment alone, highlighting the potential need for surgical intervention. The CT scan corroborates these findings, showing multiple small loculations that could limit the efficacy of medical management and hinder complete resolution of the infection.

Despite the slight radiographic improvement, the patient's clinical status has shifted. Her respiratory rate has decreased further to 24 breaths per minute, and her oxygen saturation has improved marginally to 92% with continued non-rebreather mask support. However, the persistent fever of 101.2°F and ongoing tachycardia at 105 beats per minute indicate that the inflammatory response remains robust. The patient also reports increasing discomfort with deeper breaths, consistent with worsening pleuritic chest pain. This development raises concerns about the potential progression of the empyema, which could lead to further complications if not addressed promptly.

In response to these findings, the healthcare team re-evaluates the plan of care. Given the persistent symptoms and imaging results, the decision is made to proceed with video-assisted thoracoscopic surgery (VATS) to drain the loculated effusion and debride any fibrous tissue impeding resolution. The team prepares the patient for the procedure, emphasizing the importance of this intervention in preventing further respiratory compromise and potential sepsis. As they await the surgical intervention, the team remains vigilant, continuously assessing the patient's hemodynamic stability and respiratory function, ready to adjust supportive measures as needed to ensure her safety and optimize outcomes.